Results of a prospective randomized trial with neoadjuvant chemotherapy in stage ib, bulky, squamous carcinoma of the cervix

Gynecologic Oncology

Volumn 49, Issue 2, 1993, Pages 156-165

  Sardi, Juan ^a   Sananes, Carlos ^a   Giaroli, Adolfo ^a   Bayo, Juana ^a   Rueda, Nidia Gómez ^a   Vighi, Susana ^a   Guardado, Nilda ^a   Paniceres, Guillermo ^a   Snaidas, Lazaro ^a   Vico, Clelja ^a   Di Paola, Guillermo ^a  

^a First Chair of Gynecology ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0027246164     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1993.1100     Document Type: Article

References (37)

1. Petterson, F. (Ed.) Annual report on the results of treatment in gynecological cancer. Stockholm, Vol. 20 (1991).
2. Van Nagell, J., Donaldson, E., Parker, J., et al. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery, Gynecol. Oncol. 5, 142 (1977).
3. Hass, J. Tumormetric measurements and morphometry in cervical cancer, Clinical obstetrics and gynaecology (E. Burghardt and J. M. Monaghan, Eds.), Bailliere-Tindall, London, p. 871 (1989).
4. Alvarez, R., Soong, S., Kinney, W et al. Identification of prognostic factors and risk groups in patients found to have nodal me-tastases at the time of radical hysterectomy for early stage squamous carcinoma of the cervix, Gynecol. Oncol. 35, 130-135 (1989).
5. Piver, M., and Chung, W. Prognostic significance of cervical Lesion size and pelvic node metastases in cervical carcinoma, Obstet. Gynecol. 46, 507 (1975).
6. Hoskins, W. Prognostic factors for risk of recurrence in Stage lb and Ila cervical cancer, Clinical obstetrics and gynaecology, (E. Burghardt and J. M. Monaghan, Eds.), Bailliere-Tindall, London, p. 817 (1989).
7. Fuller, A., Elliot, N., Kosloff, C., et al. Determinants increased risk of recurrence in patients undergoing radical surgery for Stage lb and Ila carcinoma of the cervix, Gynecol. Oncol. 32, 146 (1988).
8. Friedlander, M., Atkinson, K., Coppleson, J., etal. The integration of chemotherapy in locally advanced carcinoma of the cervix, Gynecol. Oncol. 19, 1 (1984).
9. Sardi, J., di Paola, G., Sananes, C. et al. A possible new trend in the management of the carcinoma cervix uteri, Gynecol. Oncol 25, 139 (1986).
10. Rustin, G., Newlands, E., et al. Cisplatinum, vincristine, methotrexate and bleomycin as initial or palliative chemotherapy for carcinoma of the cervix, Eur. J. Gynecol. Oncol. 8, 337 (1987).
11. Kim, D., Moon, H., Hwang, Y., et al. Preoperative adjuvant chemotherapy in the treatment of cervical cancer with bulky tumor, Gynecol. Oncol. 29, 322 (1988).
12. Valle, J., Rezende, M., et al. Neoadjuvant and adjuvant chemotherapy with ABC and modified radical hysterectomy in cancer of the cervix Stage III, Proc. Am. Soc. Clin. Oncol. 4, c486 (1985). [abstract]
13. Kaplan, E., and Meier, P. Non parametric estimation for incomplete observations, J. Am. Stat. Assoc. 53, 457 (1958).
14. Peto, R., Pike, M., Armitage, P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II analysis and examples, Br. J. Cancer 35, 1 (1978).
15. Cox, D. R. Regression models and life tables, J. R. Stat. Soc. 34, 187 (1972).
16. Sardi, J., Sananes, C., Giaroli, A., etal. Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri, Gynecol. Oncol 8, 486-493 (1990).
17. Mancusso, S., Debenedetti, P., and Greggi, S. Neoadjuvant chemotherapy in advanced cervical carcinoma, Eur. J. Gynecol. Oncol. 8, 335 (1987).
18. Alvarez, R. D., Potter, M., Soong, S., et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated Stage lb cervical cancer patients, Gynecol. Oncol. 43, 108-112 (1991).
19. Mendenhall, W., Thor, T., Bova, V., et al. Prognostic and treatment factors affecting pelvic control of Stage lb and II a-b carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 53, 2649 (1984).
20. Morrow, P., and Townsend, D. Synopsis of gynecologic oncology, Wiley, New York, p. 99 (1981).
21. Disaia, P., and Creasman, W. Clinical gynecologic oncology, Mosby, Washington, DC, p. 67 (1989).
22. Berek, J., and Hacker, N. Practical gynecologic oncology, Williams and Wilkins, Baltimore, p. 241 (1990).
23. Rutledge, F., Smith, J., and Fletcher, G. Clinical studies with ad-junctivc surgery and irradiation therapy in carcinoma of the cervix uteri, Cancer 38, 596 (1976).
24. Weems, D., Mendenhall, W., Bova, F., et al. Carcinoma of the uterine cervix Stage Ib-IIa-IIb 6 cm in diameter: Irradiation alone vs preoperative irradiation and surgery, Int. J. Radiat. Oncol. Biol. Phys. 11, 1911 (1985).
25. Perez, C., and Koo, M. Radiation therapy alone or combined with surgery in the treatment of barrel-shaped carcinoma of the uterine cervix, Int. J. Radiat. Oncol. Biol. Phys. 11, 1903 (1985).
26. Potter, M., Alvarez, R., Shingleton, H., et al. Early invasive cervical cancer with pelvic lymph node involvement: To complete or not to complete radical hysterectomy? Gynecol. Oncol. 37, 78 (1990).
27. Burghardt, E., Bakltzer, J., Tulusan, A., et al. Results of surgical treatment of 1028 cervical cancers with volumetry. Abstracts of the 3rd. Meeting of the International Society of Gynecological Cancer, Cairns, Australia, p. 20 (1991).
28. Burghardt, E., Haas, J., and Girardi, F. The significance of the parametrium in the operative treatment of cervical cancer. Clinical obstetrics and gynaecology, (E. Burghardt and J. M. Monaghan, Eds.), Bailliere-Tindall, London, p. 879 (1989).
29. Benedetti Panici, P., Scambia, G., Baiocchi, G., et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma, Cancer 67, 372 (1991).
30. Kim, D., Moon, H., Kim, K., etal. Two years survival: Preoperative adjuvant chemotherapy in the treatment of cervical cancer Stage lb and II with bulky tumors, Gynecol. Oncol. 33, 225 (1989).
31. Giaroli, A., Sananes, C., and Sardi, J. Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival, Gynecol. Oncol. 39, 34 (1989).
32. Kinney, W., Alvarez, R., Reid, G., et al. Value of adjuvant whole pelvis irradiation after Wertheim hysterectomy for early stage squamous carcinoma of the cervix with pelvic nodal metastases: A matched control study, Gynecol. Oncol. 34, 258 (1989).
33. Belloni, C., Maschio, A., Colombo, G., et al. Prospects of neoadjuvant chemotherapy in the treatment of cervical cancer, Cervix 8, 209 (1990).
34. Horng, C., Chyong, L., Mingshen, C., et al. Preliminary results of radiotherapy and chemotherapy with cir-platinum, vincristine, and bleomycin in bulky advanced cervical carcinoma, Gynecol. Oncol. 44, 182 (1992).
35. Chauvergne, J., Rohart, J., Heron, J., et al. Randomized phase III trial of neoadjuvant chemotherapy and radiotherapy vs. radiotherapy alone in Stage Illb carcinoma of the cervix, Abstrt. Proc. Am. Soc. Clin. Oncol. 7, 524 (1988).
36. Soudhani, L., Gil, R., and Allan, S. Randomized trial of neoadjuvant chemotherapy followed by pelvic radiotherapy alone in Stage Illb carcinoma of the cervix, Abstr. Proc. Am. Soc. Clin. Oncol. 7, 538 (1989).
37. Park, N. Neoadjuvant chemotherapy to radiation and surgery: 15th International Cancer Congress, p. 1214 (1990). [Abstracts]